Establishes a five-business-day response period for Medicaid and private insurers to pre-authorization claims for oncology patients.

The bill mandates a five-business-day window for both Medicaid and private insurers to respond to pre-authorization claims for testing and treatments made by physicians on behalf of oncology patients. If an insurer fails to respond within this period, the physician is authorized to proceed with the necessary care, and the insurer will be liable for payment. This act aims to ensure timely access to critical medical services for cancer patients.

Establishes a five-business-day response period for Medicaid and private insurers to pre-authorization claims for oncology patients.

The bill mandates a five-business-day window for both Medicaid and private insurers to respond to pre-authorization claims for testing and treatments made by physicians on behalf of oncology patients. If an insurer fails to respond within this period, the physician is authorized to proceed with the necessary care, and the insurer will be liable for payment. This act aims to ensure timely access to critical medical services for cancer patients.